Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

My Hedhammar

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Macromolecular Bioscience|January 20, 2023
Scalable Production of Monodisperse Bioactive Spider Silk NanowiresLinnea Gustafsson, Mathias Kvick, Carolina Åstrand, et al.
Journal of Molecular Biology|October 5, 2010
A pH-dependent dimer lock in spider silk proteinMichael Landreh, Glareh Askarieh, Kerstin Nordling, et al.
New Biotechnology|October 10, 2021
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodiesSara Mravinacova, Malin Jönsson, Wanda Christ, et al.
Biofabrication|January 28, 2026
Recombinant spider silk membranes promote human renal epithelial differentiation and functionAlina Meyer, Lea-Maria Mayer, Linnea Gustafsson, et al.
Scientific Reports|March 5, 2021
Antibodies to SARS-CoV-2 and risk of past or future sick leaveJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Nature Communications|October 9, 2020
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in SwedenAnn-Sofie Rudberg, Sebastian Havervall, Anna Månberg, et al.
Plos One|January 12, 2022
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infectionSebastian Havervall, August Jernbom Falk, Jonas Klingström, et al.
The Journal of Infectious Diseases|February 13, 2021
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care WorkersJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Journal of Internal Medicine|August 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19Sebastian Havervall, Henry Ng, August Jernbom Falk, et al.
Immunity, Inflammation and Disease|March 29, 2022
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatologyIda Laurén, Sebastian Havervall, Henry Ng, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Macromolecular Bioscience|January 20, 2023
Scalable Production of Monodisperse Bioactive Spider Silk NanowiresLinnea Gustafsson, Mathias Kvick, Carolina Åstrand, et al.
Journal of Molecular Biology|October 5, 2010
A pH-dependent dimer lock in spider silk proteinMichael Landreh, Glareh Askarieh, Kerstin Nordling, et al.
New Biotechnology|October 10, 2021
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodiesSara Mravinacova, Malin Jönsson, Wanda Christ, et al.
Biofabrication|January 28, 2026
Recombinant spider silk membranes promote human renal epithelial differentiation and functionAlina Meyer, Lea-Maria Mayer, Linnea Gustafsson, et al.
Scientific Reports|March 5, 2021
Antibodies to SARS-CoV-2 and risk of past or future sick leaveJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Nature Communications|October 9, 2020
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in SwedenAnn-Sofie Rudberg, Sebastian Havervall, Anna Månberg, et al.
Plos One|January 12, 2022
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infectionSebastian Havervall, August Jernbom Falk, Jonas Klingström, et al.
The Journal of Infectious Diseases|February 13, 2021
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care WorkersJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.
Journal of Internal Medicine|August 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19Sebastian Havervall, Henry Ng, August Jernbom Falk, et al.
Immunity, Inflammation and Disease|March 29, 2022
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatologyIda Laurén, Sebastian Havervall, Henry Ng, et al.
Pageof 8